Delving Into Participation Trends in Renal Cell Carcinoma Studies

Exploring Engagement Dynamics Among Individuals Impacted by Renal Cell Carcinoma

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06093568

Enrollment

500

Registered

2023-10-23

Start date

2024-11-30

Completion date

2026-11-30

Last updated

2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma

Keywords

Renal Cell Carcinoma

Brief summary

The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient has been diagnosed with renal cell carcinoma * Patient is a minimum of 18 years or older * Patient has self-identified as planning to enroll in a clinical study

Exclusion criteria

* Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant

Design outcomes

Primary

Measure	Time frame
Number of patients who decide to participate in a renal cell carcinoma clinical study	3 months
Rate of patients who remain in renal cell carcinoma clinical trial to trial completion	12 months

Countries

United States

Contacts

Primary ContactMichael B Gill

bask@withpower.com4159004227

Outcome results